A comprehensive view of Biomedical Advanced Research and Development Authority (BARDA). This page highlights a small sample of our full coverage.
For real-time access, please log in to your Government & Public Policy Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Moderna may halt midstage Zika vaccine development without additional external funding despite US financial support; decision draws into question the future of the most advanced vaccine in the company's public health pipeline
Published: March 15, 2024 by FierceBiotech
BARDA selects Thermo Fisher Scientific's PPD clinical research business to conduct Phase 2 trial investigating treatments for acute respiratory distress syndrome; study to evaluate three host-directed therapeutics at multiple sites in the US
Published: January 11, 2024 by Wireless News
CastleVax receives BARDA Project NextGen award valued at up to US$338M to advance intranasal NDV-based COVID-19 booster vaccine into Phase 2b clinical efficacy testing
Published: October 19, 2023 by Targeted News Service (Press Releases)
Regeneron receives funding from US Government’s Project NextGen to support clinical development of new COVID-19 monoclonal antibody therapy for the prevention of SARS-CoV-2 infection; funding could total $326.0M
Published: August 22, 2023 by Regeneron Pharmaceuticals Inc.

Ask us about our Government & Public Policy market view

Trending Chart

Interactive chart with headline count